Bucharest Meeting
The 8th Euromene Coast Action meeting was held in Bucharest on 14th February 2019 with a welcoming at the Royale Hotel by the local chairman Carmen Adella Sirbu.
The following meetings occurred:
- Management Committee Meeting
- Modra Murovska, Current GP3 situation - implemented measures and planned measures.
- Fernando Estévez-López, Slobodan Sekulic, Activities of WG1 after London meeting (what is done, results).
- Carmen Scheibenbogen, Enrica Capelli, Activities of WG2 after London meeting (what is done, results).
- Derek Pheby, Activities of WG3 after London meeting (what is done, results).
- Elin Bole Strand, Jerome Authier, Activities of WG4 after London meeting (what is done, results).
- Carmen Adella Sirbu, current situation with STSM. How to increase activity of ECIs in participating countries.
- Lorenzo Lorusso, Evelina Shikova, Interaction with the Cost Academy on dissemination (what is done, how to increase dissemination activity).
- Lorenzo Lorusso, Anne Marit Mengshoel, Webpage, information and involvement of SMS and patients organizations.
- All MC members, International conferences/congresses, local activities (activities in the participating countries) planned during GP3.
- Other issues (prepared and submitted projects, next MC meeting etc.)
- Clarification of the WGs plan for the next GP4 period
- Working Group 2 Meeting
Leader Carmen Scheibenbogen,
Enrica Capelli
Update Biomarker Studies
- Update new biomarker and multiparameter studies (metabolic, autoantibodies)
- Ongoing multiparameter study
Biomarkers to subgroup ME/CFS
Preparation of document with recommendations for biomarker usage and development of biomarker
Enrica Capelli, Summary on autoantibodies.
Francisco Westermeier, Presentation about endothelial function in ME/CFS focused on potential biomarkers.
Update Biomarker Studies
- Update new biomarker and multiparameter studies (metabolic, autoantibodies)
- Ongoing multiparameter study
Biomarkers to subgroup ME/CFS
Preparation of document with recommendations for biomarker usage and development of biomarker
Enrica Capelli, Summary on autoantibodies.
Francisco Westermeier, Presentation about endothelial function in ME/CFS focused on potential biomarkers.
- Working Group 4 Meeting
- Jeromie Authier Presentation of achieved results corresponding to the GP3 work plan. Anne-Marit Mengshoels’ presentation Effects of non-pharmacological interventions and patients’experiences of participating in such interventions.
- Luis Nacul, Report of Protocol for ME/CFS diagnostic (Includes recommendation for research purposes)
- Jose Alegre/Olli Polo, Report on Symptom management and relief for ME/CFS (pharmacological)
- Giorgos Sakkas /Ruud Vermulen, Report on draft for European Landscape on Diagnosis of ME/CFS for publication by
- Jerome Authier/Jean Dominique, Report on a draft of Neuropsychological review procedures on ME/CFS
- Discussion on next steps for:
- Alignment of contents with outputs from Working Groups 1 (Epidemiology); 2 (Biomarkers); and 3 (Socio-Economics),
- Production of first final draft of document with recommendations from WGs,
- Planning inputs from the patient community and Charities,
- Planning Dissemination.
European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
COST action CA15111Agenda 14 February 2019, Bucharest, Romania
Download Agenda
Viața Medicală
Oboseala cronică - cum o prevenim cum o depistăm, cum o tratăm
Download Article